![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EU Buys $74 Million Worth of Remdesivir
EU Buys $74 Million Worth of Remdesivir
The European Commission signed a $74 million contract with Gilead Sciences for a supply of remdesivir for treatment for 30,000 patients with severe COVID-19 over the next few months.
The European Medicines Agency approved remdesivir this month, marketed as Veklury, for treatment of COVID-19 patients with pneumonia requiring supplemental oxygen.
The commission said it plans to procure a further supply of the antiviral to cover additional needs in the future.
Upcoming Events
-
21Oct